Relationship Between Drug Compliance, Coping with Stress, and Social Support in Patients with Bipolar Disorder

Bipolar hastalarda ilaç uyumunun stresle başetme ve sosyal destekle ilişkisiAmaç: Bipolar bozukluğun tekrarlama oranı oldukça yüksektir. Geçirilen her atak yeni bir atak geçirme riskini arttırır. Tedavide ilk seçenek ilaç tedavisidir. Ancak hastaların ilaç tedavisine uyumla ilgili ciddi sorunları bulunmaktadır. Bu çalışma bipolar hastaların ilaç uyumunu belirlemek, stresle başetme ve sosyal destekle ilişkisini incelemek amacı ile yapılmıştır. Yöntem: Araştırmanın evrenini bir devlet hastanesine 2011 yılında bipolar bozukluk tanısı ile kayıtlı olan, il merkezinde yaşayan, ek psikiyatrik tanısı olmayan 280 hasta, örneklemi ise telefonla aranarak araştırmaya katılmayı ve ev ziyaretini kabul eden 150 hasta oluşturdu. Evreni oluşturan hastalardan 112 kişiye telefon ve adres değişikliği, 18 kişiye ise ev ziyaretini kabul etmeme nedeni ile ulaşılamamıştır. Veriler, "Kişisel Bilgi Formu", "Morisky Uyum Ölçeği", "Çok Boyutlu Algılanan Sosyal Destek Ölçeği" ve "Stresle Başa Çıkma Tarzları Ölçeği" ile toplandı. İlaç uyumu iyi olan ve ilaç uyumu olmayan hastalar stresle baş etme biçimleri ve sosyal destek puanları açısından karşılaştırıldı.Bulgular: Çalışmada hastaların %55.3'ünün ilaç tedavisine uyumsuz olduğu belirlendi. Uyumu kötü olan hastalar stresle baş etme tarzları alt boyutlarından çaresiz yaklaşım ve boyun eğici yaklaşımı daha fazla kullanıyorlardı. Sosyal destek açısından ilaç tedavisine uyumu olan ve olmayan hastalar arasında bir fark yoktu. Sonuç: Bipolar hastalarda etkili baş etme yöntemlerinin geliştirilmesinin ilaç uyumunu arttırmada bir çözüm olabileceği düşünüldü.

Bipolar hastalarda ilaç uyumunun stresle başetme ve sosyal destekle ilişkisi

Relationship between drug compliance, coping with stress, and social support in patients with bipolar disorder Objective: In bipolar disorder, recurrence rate is relatively high. With each episode, the risk of a new episode is increased. The first choice is drug treatment. However, patients have serious difficulties in drug compliance. This study was conducted to investigate drug compliance of patients with bipolar disorder, and to determine relationships between drug compliance, coping with stress, and social support.Method: The target population of the study included 280 patients registered in a state hospital with the diagnosis of bipolar disorder in 2011, residing in the city center, and having no other psychiatric disorders. Of these 280 patients, 150 who agreed to participate in the study and accepted to be visited at home after they were telephoned comprised the study sample. Of the patients in the target population, phone numbers and addresses were changed in 112 patients, and 18 refused to have a home-visit, so they were excluded from the study. Data were collected using the personal information form, Morisky Medication Adherence Scale, Multidimensional Scale of Perceived Social Support and Ways of Coping Scale. Results: In this study, it was determined that 55.3% of the patients did not comply with drug treatment. The patients with poor drug compliance preferred mainly desperate approach and submissive approach subdimensions of the Ways of Coping Scale more. There was no difference between patients with and without drug compliances in terms of social support.Conclusions: It is considered that development of effective coping strategies would promote drug compliance in patients with bipolar disorder.

PDF

___

Turhan N. Bipolar Disorder: A Cross-sectional Evaluation. Postgraduate Thesis. Department of Psychiatry, Medical Faculty, Cukurova University, Adana, 2007. (Turkish)
Miasso AI, Monteschi M, Giacchero KG. Bipolar affective disorder: medication adherence and satisfaction with treatment and guidance by the health team in a mental health service. Rev Lat Am Enfermagem 2009; 17:548-556. [CrossRef]
Crowe M, Wilson L, Inder M. Patients' reports of the factors influencing medication adherence in bipolar disorder-an integrative review of the literature. Int J Nurs Stud 2011; 48:894- 903. [CrossRef]
World Health Organization. The Global Burden of Disease: 2004 Update. WHO Pres. Geneva. 2008: 33.
Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina- Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011;
O'Connell RA, Mayo JA, Flatow L. Cuthbertson B, O'Brien BE. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991; 159:123-129. [CrossRef]
Gitlin MJ, Swendsen J, Heler TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry 1995; 152:1635- 1640. [CrossRef]
Kora K, Saylan M, Akaya C, Karamustafalioglu N, Tomruk N, Yasan A, Oral T. Predictive factors for time to remission and recurrence in patients treated for acute mania: health outcomes of manic episodes (HOME) study. Prim Care Companion J Clin Psychiatry 2008; 10:114-119. [CrossRef]
Tang CH, Hsieh MH, Hung ST, Lee IH, Lin YJ, Yang YK. One- year post-hospital medical costs and relapse rates of bipolar disorder patients in Taiwan: a population-based study. Bipolar Disord 2010; 12:859-865. [CrossRef]
Eroglu MZ, Ozpoyraz N. Long-term treatment in bipolar disorder. Current Approaches in Psychiatry 2010; 2:206-236. (Turkish)
Gonul AS, Oguz A, Yabanoglu I, Esel E. Lamotrigine treatment in the management of treatment refractory bipolar patients. Bulletin of Clinical Psychopharmacology 2000; 10:171-175. (Turkish)
Isik E. Mood Disorders: Depression and Bipolar Disorders. Gorsel Sanatlar Matbaacilik, Istanbul, 2003. (Turkish)
Darling CA, Olmstead SB, Lund EV, Fairclough JF. Bipolar disorder: medication adherence and life contentment. Arch Psychiatr Nurs 2008; 22:113-126. [CrossRef]
Mahmood KT, Khalid N, Makhdum Z. Adherence to drug therapy in psychiatric patients. Journal of Pharmaceutical Sciences and Research 2010; 2:700-703.
Sofuoglu S, Turan MT. Problems of comliance with antipsychotic drugs: In relation to their extrapyramidal side effects. Anadolu Psikiyatri Derg 2000; 1:100-106. (Turkish)
Oral ET, Sahin S, Akman D, Verimli A. Compliance in patients bipolar mood disorder: Is it enough to say "Let's assume that you are diabetic? Anadolu Psikiyatri Derg 2002; 3:212-222. (Turkish)
Colom F. Achieving remission and recovery in bipolar disorder. J Clin Psychiatry 2010; 71:e32. [CrossRef]
Colom F, Vieta E, Tacchi MJ, Sanchez-Moreno J, Scott J. Identifying and improving non-adherence in bipolar disorders. Bipolar Disord 2005; (Suppl.5):24-31. [CrossRef]
Pompili M, Serafini G, Casale DA, Rigucci S, Innamorati M, Girardi P, Tatarelli R, Lester D. Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk. Expert Rev Neurother 2009; 9:985-1004. [CrossRef]
Riley W, Velligan D, Sajatovic M, Valenstein M, Safren S, Lewis- Fernandez R, Weiden P, Ogedegbe G. Adherence to psychiatric treatments. CML-Psychiatry 2009; 20:89-96.
Kripalani S, Risser J, Gatti ME, Jacobson TA. Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease. Value Health 2009; 12:118-123. [CrossRef]
Zeber JE, Copeland LA, Good CB, Fine MJ, Bauer MS, Kilbourne AM. Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. J Affect Disord 2008; 107:53- 62. [CrossRef]
Sajatovic M, Chen P, Dines P, Shirley ER. Psychoeducational approaches to medication adherence in patients with bipolar disorder. Disease Management and Health Outcomes 2007; 15:181-192. [CrossRef]
Kilic C, Esel E. The stress-reaction process. Bulletin of Clinical Psychopharmacology 2002; 12:41-48.
Hendryx M, Green CA, Perrin NA. Social support, activities, and recovery from serious mental illness. STARS study findings. J Behav Health Serv Res 2009; 36:320-329. [CrossRef]
Hutchison C. Social support: factors to consider when desingning studies that measure social support. J Adv Nurs 1999; 29:1520- 1526. [CrossRef]
Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP. Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines. J Psychiatr Pract 2010; 16:34-45. [CrossRef]
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adeherence. Medical Care 1986; 24:1:67-74. [CrossRef]
Yilmaz S. Side Effects of Drugs in Psychiatry Patients and Drug Compliance. Postgraduate Thesis. Health Sciences Institute, Istanbul University, Istanbul, 2004. (Turkish)
Lazarus RS, Folkman S. Stress, appraisal, and coping. New York: Springer 1984.
Sahin HN, Durak A. A brief coping styles inventory for university students. Turkish Journal of Psychology 1995; 10:56-73. (Turkish)
Zimet GD, Dahlem NW, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social Support. J Pers Assess 1988; 52:30-41. [CrossRef]
Eker D, Arkar H. Factorial structure, validity, and reliability of the multidimensional scale of perceived social support. Turkish Journal of Psychology 1995; 10:45-53. (Turkish)
Eker D, Arkar H, Yildiz H. Factorial structure, validity, and reliability of revised form of the multidimensional scale of perceived social support. Turk Psikiyatri Derg 2001; 12:17-25. (Turkish)
Harkin S. Evaluation of Efficacy of Psychoeducational Model in Increasing Treatment Compliance of Patients with Bipolar Disorders. Postgraduate Thesis. Health Sciences Institute, Duzce University, Duzce, 2008. (Turkish)
Savas HA, Unal A, Virit O. Treatment adherence in bipolar disorder. Journal of Mood Disorders 2011; 1:95-102. [CrossRef]
Sajatovic M, Valenstein M, Blow F, Ganoczy D, Ignacio R. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv 2007; 58:855-863. [CrossRef]
Keck PE, McElroy SL, Strakowski SM, Bourne ML, West SA. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull 1997; 33:87-91.
Copeland LA, Zeber JE, Salloum IM, Pincus HA, Fine MJ, Kilbourne AM. Treatment adherence and illness insight in veterans with bipolar disorder. J Nerv Ment Dis 2008; 196:16-21. [CrossRef]
Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord 2006; 8:232-241. [CrossRef]
Colom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gasto C. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry 2000; 61:549-555. [CrossRef]
Rosa AR, Marco M, Fachel JM, Kapczinski F, Stein AT, Barros HM. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:217-224. [CrossRef]
Gonzalez-Pinto A, Reed C, Novick D, Bertsch J, Haro JM. Assessment of medication adherence in a cohort of patients with bipolar disorder. Pharmacopsychiatry 2010; 43:263-270. [CrossRef]
Misdrahi D, Llorca PM, Lancon C, Bayle FJ. Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications. Encephale 2002; 28:266-272. (French)
Christensen MV, Kessing LV. Clinical use of coping in affective disorder, a critical review of the literature. Clin Pract Epidemiol Ment Health 2005; 1-20.
Greenhouse WJ, Meyer B, Johnson SL. Coping and medication adherence in bipolar disorder. J Affect Disord 2000; 59:237-241. [CrossRef]
Lam D, Wong G, Sham P. Prodromes, coping strategies and course of illness in bipolar affective disorder-a naturalistic study. Psychol Med 2001; 31:1397-1402. [CrossRef]
Ryu V, Song D, Ha R, Ha K, Cho H. Prodromes and coping types in bipolar patients with nonpsychotic or psychotic mania. Compr Psychiatry 2012; 53:732-739. [CrossRef]
Unal S, Cakil G, Elyas Z. Characteristics of psycotic patients who did not attend follow-up visits after discharge. Anatolian Journal of Psychiatry 2006; 7:69-75. (Turkish)
Cakir F, Ilnem C, Yener F. Compliance in follow-up and treatment after discharge among chronic psychotic patients. Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2010; 23:50-59. [CrossRef]
Pevalin DJ, Goldberg DP. Social precursors to onset and recovery from episodes of common mental illness. Psychol Med 2003; 33:299-306. [CrossRef]
Sajatovic M, Levin J, Fuentes-Casiano E, Cassidy KA, Tatsuoka C, Jenkins JH. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication. Compr Psychiatry 2011; 52:280-287. [CrossRef]
Corrigan PW, Phelan SM. Social support and recovery in people with serious mental illnesses. Community Ment Health J 2004; 40:513-523. [CrossRef]
Sherbourne CD, Hays RD, Wells KB. Personal and psychosocial risk factors for physical and mental health outcomes and course of depression among depressed patients. J Consult Clin Psychol 1995; 63:345-355. [CrossRef]
Rabinovitch M, Cassidy C, Schmitz N, Joober R, Malla A. The influence of perceived social support on medication adherence in first-episode psychosis. Can J Psychiatry 2013; 58:59-65.
Kelleci M, Ata EE. Drug compliance of patients hospitalized in the psychiatry clinic and the relationship with social support. J Psychiatr Nurs 2011; 2:105-110.
Scheurer D, Choudhry N, Swanton KA, Matlin O, Shrank W. Association between different types of social support and medication adherence. Am J Manag Care 2012; 18:e461-467.
Byerly MJ, Nakonezny PA, Rush AJ. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr Res 2008; 100:60-69. [CrossRef]
Velligan DI, Lam YW, Glahn DC, Barrett JA, Maples NJ, Ereshefsky L, Miller AL. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 2006;